United States · FDA National Drug Code directory

Losartan Potassium and Hydrochlorothiazide

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-0152_d2184bfc-9552-47ce-a410-a259c0dbc7df
Product NDC
71335-0152
Form
TABLET, FILM COATED
Composition / generic term
Losartan Potassium and Hydrochlorothiazide
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20101006
Source listing expiry
20261231

Source-listed ingredients

  • LOSARTAN POTASSIUM — 50 mg/1
  • HYDROCHLOROTHIAZIDE — 12.5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 90 TABLET, FILM COATED in 1 BOTTLE (71335-0152-1) · 71335-0152-1
  • 60 TABLET, FILM COATED in 1 BOTTLE (71335-0152-2) · 71335-0152-2
  • 30 TABLET, FILM COATED in 1 BOTTLE (71335-0152-3) · 71335-0152-3
  • 120 TABLET, FILM COATED in 1 BOTTLE (71335-0152-4) · 71335-0152-4
  • 58 TABLET, FILM COATED in 1 BOTTLE (71335-0152-5) · 71335-0152-5
  • 100 TABLET, FILM COATED in 1 BOTTLE (71335-0152-6) · 71335-0152-6
  • 180 TABLET, FILM COATED in 1 BOTTLE (71335-0152-7) · 71335-0152-7
  • 1000 TABLET, FILM COATED in 1 BOTTLE (71335-0152-8) · 71335-0152-8

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →